ArticleFrontiers in pharmacology2025
Drug-therapy-related problems and pharmacist interventions in the medical ward in northeast Ethiopia: focus on types, acceptability, and impacts.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to identify drug-therapy-related problems, possible interventions, acceptability, and impacts of the interventions among patients admitted to the medical ward. Methods: A hospital-based prospective interventional study was conducted in Hakim Gizaw Hospital, Debre Berhan City, Ethiopia. The sample size for the study was determined using a single proportion formula and 183 participants were recruited accordingly. Data were collected by two clinical pharmacists using a predesigned tool. The drug-therapy-related problems, interventions, and acceptability of the interventions were categorized on the basis of the Pharmaceutical Care Network Europe V.9.1 tool. The impacts of the interventions were then assessed using the clinical, economic, and organizational multidimensional tool. The data were analyzed using SPSS version 26 software. Result: Drug-therapy-related problems were identified in 27.3% of the patients, with an average incidence of 2.36 ± 0.76 events per patient. The treatment-effectiveness-related problems accounted for half (60/121) of these drug-related problems, followed by drug-selection-related causes (31/121, 26.3%), dose selection (19/121, 16.1%), and other undefined but related causes (19/121, 16.1%). A total of 143 interventions were delivered by the clinical pharmacists, of which those discussed with the prescriber (55, 38.4%) were the most frequent type. Approximately three-fourths (106/143) of these interventions were accepted. Among the pharmacist interventions, 36.4% had minor, 8.4% had major, and 4.9% showed negative clinical impacts. Economically speaking, 48.2% of the interventions were found to reduce treatment costs; organizationally, approximately 28.7% of the interventions had improved the quality of care while 14.0% had worsened it. The duration of hospitalization, comorbidities, and admission locations were observed to significantly influence the drug-related problems. Conclusion: There was a high prevalence of drug-therapy-related problems as well as high acceptance rate of interventions in the medical ward, which were found to have pronounced economic, clinical, and organizational impacts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.